Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Menopause Drug Market Size study, by Stages Type (Perimenopause, Menopause, Post menopause) by Treatment Type (Non-Hormonal Treatment, Hormonal Treatment, Herbal Supplements) by Product Type (Patch, Pill, Gel, Injectable, Cream, Others) by Route of Administration Types (Oral, Injectable, Topical) by End-Users (Hospitals, Homecare, Specialty Clinics, Others) and Regional Forecasts 2022-2028

  • BIZ4950947
  • 200 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Menopause Drug Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. (Mar) Menopause Drug is a type of walk-in clinic that provides ambulatory care in a dedicated medical facility outside of a conventional emergency room (ER). Also, the Menopause Drug is used for treating injuries and illness that need immediate care. The increase in percentage of women aged 40-65 years impacted them the most has led the adoption of Menopause Drug across the forecast period. According to a survey conducted in 2021 by Statista, 1 in 6 women aged 40 to 65 claimed hot flashes were the most bothersome symptom of menopause. Another 15% experienced weight increase, with vaginal dryness and uncomfortable sex affecting the majority of women (12%). As of 2021, this statistic shows the percentage of women aged 40 to 65 in the United States who reported that menopause symptoms affected them the most. Also, with the increasing research and development in the drugs, the adoption & demand for Menopause Drug is likely to increase the market growth during the forecast period. However, low awareness regarding this drug impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Menopause Drug Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the high prevalence of unhealthy lifestyle and rising introduction of novel drugs in this region. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2022-2028. Factors such as increase in the vulnerable aging population of menopause women and increase in the demand of novel therapies would create lucrative growth prospects for the Menopause Drug Market across Asia-Pacific region.

Major market player included in this report are:

Teva Pharmaceutical Industries Ltd.

Eli Lilly and Company

Cipla Inc

Allergan

Pfizer, Inc

Novo Nordisk A/S

Novartis AG

Merck & Co., Inc

Emcure

Viramal,

EuroPharma USA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Stages Type:

Perimenopause

Menopause

Post menopause

By Treatment Type:

Non-Hormonal Treatment

Hormonal Treatment

Herbal Supplements

By Product Type:

Patch

Pill

Gel

Injectable

Cream

Others

By Route of Administration Type:

Oral

Injectable

Topical

By End Users:

Hospitals

Homecare

Specialty Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Menopause Drug Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Menopause Drug Market, by Region, 2020-2028 (USD Billion)

1.2.2. Menopause Drug Market, by Stages Type, 2020-2028 (USD Billion)

1.2.3. Menopause Drug Market, by Treatment Type, 2020-2028 (USD Billion)

1.2.4. Menopause Drug Market, by Product Type, 2020-2028 (USD Billion)

1.2.5. Menopause Drug Market, by Route of Administration Type, 2020-2028 (USD Billion)

1.2.6. Menopause Drug Market, by End Users, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Menopause Drug Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Menopause Drug Market Dynamics

3.1. Menopause Drug Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Increasing percentage of women aged 40-65 years who are suffering from menopause

3.1.2. Market Challenges

3.1.2.1. Low awareness regarding this drug

3.1.3. Market Opportunities

3.1.3.1. Increasing research and development in the drugs

Chapter 4. Global Menopause Drug Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Menopause Drug Market, by Stages Type

6.1. Market Snapshot

6.2. Global Menopause Drug Market by Stages Type, Performance - Potential Analysis

6.3. Global Menopause Drug Market Estimates & Forecasts by Stages Type 2019-2028 (USD Billion)

6.4. Menopause Drug Market, Sub Segment Analysis

6.4.1. Perimenopause

6.4.2. Menopause

6.4.3. Post menopause

Chapter 7. Global Menopause Drug Market, by Treatment Type

7.1. Market Snapshot

7.2. Global Menopause Drug Market by Treatment Type, Performance - Potential Analysis

7.3. Global Menopause Drug Market Estimates & Forecasts by Treatment Type 2019-2028 (USD Billion)

7.4. Menopause Drug Market, Sub Segment Analysis

7.4.1. Non-Hormonal Treatment

7.4.2. Hormonal Treatment

7.4.3. Herbal Supplements

Chapter 8. Global Menopause Drug Market, by Product Type

8.1. Market Snapshot

8.2. Global Menopause Drug Market by Product Type, Performance - Potential Analysis

8.3. Global Menopause Drug Market Estimates & Forecasts by Product Type 2019-2028 (USD Billion)

8.4. Menopause Drug Market, Sub Segment Analysis

8.4.1. Patch

8.4.2. Pill

8.4.3. Gel

8.4.4. Injectable

8.4.5. Cream

8.4.6. Others

Chapter 9. Global Menopause Drug Market, by Route of Administration Type

9.1. Market Snapshot

9.2. Global Menopause Drug Market by Route of Administration Type, Performance - Potential Analysis

9.3. Global Menopause Drug Market Estimates & Forecasts by Route of Administration Type 2019-2028 (USD Billion)

9.4. Menopause Drug Market, Sub Segment Analysis

9.4.1. Oral

9.4.2. Injectable

9.4.3. Topical

Chapter 10. Global Menopause Drug Market, by End Users

10.1. Market Snapshot

10.2. Global Menopause Drug Market by End Users, Performance - Potential Analysis

10.3. Global Menopause Drug Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)

10.4. Menopause Drug Market, Sub Segment Analysis

10.4.1. Hospitals

10.4.2. Homecare

10.4.3. Specialty Clinics

10.4.4. Others

Chapter 11. Global Menopause Drug Market, Regional Analysis

11.1. Menopause Drug Market, Regional Market Snapshot

11.2. North America Menopause Drug Market

11.2.1. U.S. Menopause Drug Market

11.2.1.1. Stages Type breakdown estimates & forecasts, 2019-2028

11.2.1.2. Treatment Type breakdown estimates & forecasts, 2019-2028

11.2.1.3. Product Type breakdown estimates & forecasts, 2019-2028

11.2.1.4. Route of Administration Type breakdown estimates & forecasts, 2019-2028

11.2.1.5. End Users breakdown estimates & forecasts, 2019-2028

11.2.2. Canada Menopause Drug Market

11.3. Europe Menopause Drug Market Snapshot

11.3.1. U.K. Menopause Drug Market

11.3.2. Germany Menopause Drug Market

11.3.3. France Menopause Drug Market

11.3.4. Spain Menopause Drug Market

11.3.5. Italy Menopause Drug Market

11.3.6. Rest of Europe Menopause Drug Market

11.4. Asia-Pacific Menopause Drug Market Snapshot

11.4.1. China Menopause Drug Market

11.4.2. India Menopause Drug Market

11.4.3. Japan Menopause Drug Market

11.4.4. Australia Menopause Drug Market

11.4.5. South Korea Menopause Drug Market

11.4.6. Rest of Asia Pacific Menopause Drug Market

11.5. Latin America Menopause Drug Market Snapshot

11.5.1. Brazil Menopause Drug Market

11.5.2. Mexico Menopause Drug Market

11.6. Rest of The World Menopause Drug Market

Chapter 12. Competitive Intelligence

12.1. Top Market Strategies

12.2. Company Profiles

12.2.1. Teva Pharmaceutical Industries Ltd.

12.2.1.1. Key Information

12.2.1.2. Overview

12.2.1.3. Financial (Subject to Data Availability)

12.2.1.4. Product Summary

12.2.1.5. Recent Developments

12.2.2. Teva Pharmaceutical Industries Ltd.

12.2.3. Eli Lilly and Company

12.2.4. Cipla Inc

12.2.5. Allergan

12.2.6. Pfizer, Inc

12.2.7. Novo Nordisk A/S

12.2.8. Novartis AG

12.2.9. Merck & Co., Inc

12.2.10. Emcure

12.2.11. Viramal,

12.2.12. EuroPharma USA

Chapter 13. Research Process

13.1. Research Process

13.1.1. Data Mining

13.1.2. Analysis

13.1.3. Market Estimation

13.1.4. Validation

13.1.5. Publishing

13.2. Research Attributes

13.3. Research Assumption

List of Tables

TABLE 1. Global Menopause Drug Market, report scope

TABLE 2. Global Menopause Drug Market estimates & forecasts by Region 2019-2028 (USD Billion)

TABLE 3. Global Menopause Drug Market estimates & forecasts by Stages Type 2019-2028 (USD Billion)

TABLE 4. Global Menopause Drug Market estimates & forecasts by Treatment Type 2019-2028 (USD Billion)

TABLE 5. Global Menopause Drug Market estimates & forecasts by Product Type 2019-2028 (USD Billion)

TABLE 6. Global Menopause Drug Market estimates & forecasts by Route of Administration Type 2019-2028 (USD Billion)

TABLE 7. Global Menopause Drug Market estimates & forecasts by End Users 2019-2028 (USD Billion)

TABLE 8. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 9. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 10. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 11. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 12. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 13. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 14. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 15. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 16. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 17. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 18. U.S. Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 19. U.S. Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 20. U.S. Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 21. Canada Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 22. Canada Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 23. Canada Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 24. UK Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 25. UK Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 26. UK Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 27. Germany Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 28. Germany Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 29. Germany Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 30. RoE Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 31. RoE Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 32. RoE Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 33. China Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 34. China Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 35. China Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 36. India Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 37. India Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 38. India Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 39. Japan Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 40. Japan Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 41. Japan Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 42. RoAPAC Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 43. RoAPAC Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 44. RoAPAC Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 45. Brazil Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 46. Brazil Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 47. Brazil Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 48. Mexico Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 49. Mexico Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 50. Mexico Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 51. RoLA Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 52. RoLA Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 53. RoLA Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 54. Row Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 55. Row Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 56. Row Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 57. List of secondary sources, used in the study of global Menopause Drug Market

TABLE 58. List of primary sources, used in the study of global Menopause Drug Market

TABLE 59. Years considered for the study

TABLE 60. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370